Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

GU Cancers 2020

2020 Genitourinary Cancers Symposium
San Francisco, CA, 13-15 February, 2020

The 2020 Genitourinary Cancers (GU) Symposium, held in San Francisco, CA, presented practice-changing data in the GU field, as well as novel insights into burning questions, from Feb 13–15.

Leading experts from across the globe presented cutting-edge data, with a focus on translating this new evidence into multidisciplinary care. Explore the news here.

Prostate Cancer

View all
1:40
The significant impact of PSMA-PET on prostate cancer staging and management
Jeremie Calais • 13 Feb 2020
KEYNOTE-921: pembrolizumab + docetaxel & prednisone for mCRPC
Daniel Petrylak • 15 Feb 2020

Bladder Cancer

View all
ATLAS update: rucaparib for bladder cancer
Petros Grivas • 16 Feb 2020
FDA approval of erdafitinib: bladder cancer impact
Arlene Siefker-Radtke • 15 Feb 2020

Trial Updates

View all
JAVELIN Renal 101: DepOR & outcomes in RCC
Martin Voss • 16 Feb 2020
CaboPoint: second-line cabozantinib for RCC
Laurence Albiges • 15 Feb 2020

Immuno-Oncology

View all
Optimizing immunotherapy duration
Hans Hammers • 15 Feb 2020
Immunotherapy with radiotherapy in RCC: is there a benefit?
Thomas Powles • 15 Feb 2020
The content of VJOncology is intended for healthcare professionals